Citation: | Shibo Wang, Panpan Li, Yongzhi Li, Jiaping Wang, Yujuan Li. Validated, Rapid and Sensitive HPLC-MS/MS Method for Determination of 7, 4'-Dihydroxylflavone in Rat Plasma and Its Application to Preliminary Pharmacokinetics[J].JOURNAL OF BEIJING INSTITUTE OF TECHNOLOGY, 2019, 28(4): 731-738.doi:10.15918/j.jbit1004-0579.18078 |
[1] |
Luo Y, Wang H, Xu X, et al. Antioxidant phenolic compounds of Dracaena cambodiana[J]. Molecules, 2010,15:8904.
|
[2] |
Bolleddula J, Srinivasulu D, Rong W, et al. Licorice flavonoids inhibit eotaxin-1 secretion by human fetal lung fibroblasts in vitro[J]. Journal of Agricultural & Food Chemistry, 2009,57:820-825.
|
[3] |
Perez-Garcia F, Ceresuela J L, Gonzalez A E, et al. Flavonoids in seed coats of Medicago arborea and M. strasseri (Leguminosae):Ecophysiological aspects[J]. Journal of Basic Microbiology,2010,32:241-248.
|
[4] |
Yang N, Patil S, Zhuge Jian, et al. Flavonoids present in anti-Asthma formula, ASHMI[J]. Phytotherapy Research, 2013,27(9):1381-1391.
|
[5] |
Liu C, Yang N, Chen X, et al. The flavonoid 7,4'-dihydroxyflavone prevents dexamethasone paradoxical adverse effect on eotaxin production by human fibroblasts[J]. Phytotherapy Research, 2017,31(3):449-458. DOI:
10.1002/ptr.5767.
|
[6] |
Liu C, Weir D, Busse P, et al. The flavonoid 7,4'-dihydroxyflavone inhibits MUC5AC gene expression, production, and secretion via regulation of NF-κB, STAT6, and HDAC2[J]. Phytotherapy Research Ptr, 2015,29:925-932.
|
[7] |
Ma Y, Zhou Y, Zhou Y, et al. Metabolism and transportation of 7,4'-dihydroxyflavone in Caco-2 cell model[J]. Herald of Medicine, 2017,36:127-131. (in Chinese)
|
[8] |
Li Y, Li G Q, Li Y, et al. Development and application of an UHPLC-MS method for comparative pharmacokinetic study of phenolic components from dragon's blood in rats under simulated microgravity environment[J]. Journal of Pharmaceutical & Biomedical Analysis, 2016,121:91-98.
|
[9] |
Wei G, Xiao S, Liu C. The pharmacokinetics of epristeride in rats and beagle dogs[J]. Acta Pharmaceutica Sinica, 2000,35:721-724.(in Chinese)
|
[10] |
Helmy S A. Therapeutic drug monitoring and pharmacokinetic compartmental analysis of sulpiride double-peak absorption profile after oral administration to human volunteers[J]. Biopharmaceutics & Drug Disposition, 2013,34:288-301.
|
[11] |
Chen S, Yang Y, Liu Y, et al. The pharmacokinetics of dauricine in rats[J]. Chinese Pharmacological Bulletin, 2001,17:225-229. (in Chinese)
|
[12] |
Yin C W, Zhang L, Lin G, et al. Intestinal first-pass glucuronidation activities of selected dihydroxyflavones[J]. International Journal of Pharmaceutics, 2009,366:14-20.
|
[13] |
Hollman P, Riceevans C. Bioavailability of flavonoids[J]. European Journal of Clinical Nutrition, 1997,51(Suppl.1):66-69.
|
[14] |
Chen Z, Zheng S, Li L, et al. Metabolism of flavonoids in human:a comprehensive review[J]. Current Drug Metabolism, 2014,15:48-61.
|